FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Healthcare Providers and Clinical Laboratory Staff
The Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers that the FDA is monitoring the potential impact of viral mutations, including an emerging variant…